Fluorescence Perfusion Imaging With Micro-Bolus Pattern Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing fluorescence-guided surgery methods struggle to objectively and quantitatively detect abnormal perfusion patterns, such as cancerous or inflammatory tissue, due to limitations in visual assessment and the inability to conduct multiple measurements without a washout period, leading to potential underestimation and increased surgical risks.

Innovation Solution

A system and method utilizing a series of controlled micro-boluses of fluorescent agents to create an oscillating input signal, allowing for continuous perfusion monitoring and real-time detection of abnormal perfusion patterns by analyzing the distortion of the input signal through body kernels, which can be superimposed onto white light images for surgical guidance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If a large bolus of fluorescent agent is administered, then signal intensity is sufficient for visual inspection, but the ability to conduct multiple measurements is limited due to washout period requirements

Engineering Contradiction:
Improvesignal intensityVSAvoidmeasurement frequency
Core Design Contradiction:
Illumination intensityVSProductivity

Solution Approach 1:

The patent divides a single large bolus administration into multiple smaller boluses administered over time. This segmentation allows the system to maintain sufficient signal intensity for each measurement while enabling multiple measurements within a reasonable time frame, eliminating the need for long washout periods between measurements.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system employs periodic administration of small boluses at controlled intervals. This periodic action creates a time-varying signal pattern that allows multiple measurements to be taken systematically, with each bolus providing a fresh signal event that can be measured before the next one is administered.

Inventive Principle:
Principle #19Periodic action

2Loss of information

If visual assessment of fluorescence inflow and outflow is used, then tissue perfusion information can be obtained, but quantitative assessment is impossible due to reliance on surgeon's visual judgment

Engineering Contradiction:
Improveperfusion informationVSAvoidquantification accuracy
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The system implements automated feedback by capturing fluorescence images, processing them through deconvolution algorithms, and generating quantitative perfusion parameter maps. This feedback loop replaces subjective visual assessment with objective computational analysis, providing precise quantification of tissue perfusion characteristics.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces the mechanical/visual assessment process with an automated computational system. Instead of relying on the surgeon's visual judgment and manual observation, the system uses image processing algorithms and deconvolution techniques to automatically extract and quantify perfusion information from fluorescence images.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Device complexity

If only one predefined area is visualized per ICG assessment, then measurement process is simple, but the ability to detect abnormal tissue across the entire surgical field is limited

Engineering Contradiction:
Improvemeasurement complexityVSAvoiddetection completeness
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The system is designed to perform multiple functions simultaneously: it can analyze multiple regions of interest, generate perfusion parameter maps for the entire surgical field, and detect both normal and abnormal tissue characteristics. This multi-functionality allows comprehensive tissue assessment without significantly increasing operational complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent transitions from analyzing a single predefined area to generating spatially-resolved perfusion parameter maps across the entire surgical field. By adding the spatial dimension to the analysis, the system can simultaneously evaluate multiple regions and identify abnormal tissue locations while maintaining a unified measurement approach.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Loss of information

If multiple measurements are conducted with a large bolus dose, then comprehensive tissue assessment is possible, but considerable washout time is required between measurements

Engineering Contradiction:
Improvetissue assessment coverageVSAvoidwashout period duration
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

By segmenting the total contrast agent dose into multiple small boluses administered at intervals, the system enables comprehensive tissue assessment across multiple measurement time points without requiring long washout periods. Each small bolus provides sufficient signal for measurement while clearing quickly enough to allow rapid sequential measurements.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The periodic administration of small boluses creates a measurement protocol where each bolus serves as a discrete measurement event. This periodic structure allows the system to conduct multiple measurements systematically, with the timing optimized to capture perfusion dynamics without requiring extended washout periods between measurements.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables real-time, continuous identification of abnormal perfusion patterns, reducing surgical risks and improving surgical precision by providing objective quantification and visual enhancement of abnormal tissue areas during surgery.

Implementation Method 1

fluorescence imaging agent, wherein the series of boluses is administered with a predefined and/or controlled duration between subsequent boluses

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20260096736A1System and method for identifying an abnormal perfusion pattern
Publication Date: 2026.04.09 PERFUSION TECH APS
  • US20260096736A1 patent drawing
  • US20260096736A1 patent drawing
  • US20260096736A1 patent drawing

AI summary

The present disclosure relates to systems and methods for continuously detecting, and optionally classifying, abnormal perfusion patterns in tissue by means of fluorescence imaging. One embodiment relates to a computer implemented method for detecting (and/or identifying) one or more areas having an abnormal perfusion pattern in tissue of a subject, for example during a medical procedure, the method comprising the steps of: continuously acquiring fluorescence images of the tissue, wherein the fluorescence images are associated with a fluorescent output signal correlated with an input signal defined by a series of boluses of at least one fluorescent imaging agent, and wherein the series of boluses is administered with a predefined and/or controlled duration between subsequent boluses, analysing the fluorescence images, identifying at least one tissue area with normal perfusion, defining a normal perfusion pattern (in an intensity domain and) in a time domain, and detecting, in the fluorescence images, possible tissue areas with abnormal (non-normal) perfusion pattern.